RESULTS OF THE IMPLEMENTATION OF THE DISEASE MANAGEMENT PROGRAM ON CHRONIC HEART FAILURE IN THE REPUBLIC OF KAZAKHSTAN
Background. Cardiovascular diseases are the leading cause of death globally, accounting for 20.5 million deaths in 2021, according to the World Heart Report, and accounting for almost a third of all deaths in the world. Many cardiovascular disease events can be prevented by changes in behavioral risk factors, such as smoking and diet, as well as pharmacological interventions. One solution addressing this issue is disease management, which seeks to enhance healthcare by lowering the expenses of treating chronically ill individuals. Disease management programs effectively enhance care quality and adherence, ultimately reducing the misuse of resources.
Aim. To analyze the results of implementing the Disease Management Program in Kazakhstan using chronic heart failure as an example over the years of implementation.
Materials and methods. The necessary statistical data on implementing the Disease Management Program in Kazakhstan were collected using the chronic heart failure example. The research material was the Salidat Kayirbekova National Scientific Research Center for Health Development statistical collections and official reports of the Research Institute of Cardiology and Internal Diseases for 2018-2022.
Results. The introduction of a disease management system for the management of chronic heart failure at the end of 2013-2022 contributed to a decrease in mortality from cardiovascular diseases by 4.3%, including from hypertension by 12%, coronary artery disease by 4%, and acute myocardial infarction by 4.8%. Quality of care within the healthcare system has advanced: patient coverage has expanded, and training sessions have been arranged for patients and healthcare professionals.
Conclusions. These findings highlight the success of the implemented strategies and underscore the importance of continuous monitoring and evaluation to enhance healthcare outcomes further. Overall, the research underscores the positive trajectory of chronic disease management in Kazakhstan, paving the way for future improvements and sustained health benefits for the population.
Akzhan Konysbekova1,2, https://orcid.org/0000-0001-6759-8041
Marat Pashimov2, https://orcid.org/0009-0004-9316-9549
Oryngul Jumagaziyeva1, https://orcid.org/0000-0003-1914-7179
Akmaral Abikulova1, https://orcid.org/0000-0001-8063-1029
Laura Seiduanova1, https://orcid.org/0000-0003-0205-2421
Ainur B. Qumar1, https://orcid.org/0000-0003-0457-7205
1 Asfendiyarov Kazakh National Medical University, Department of Health Policy and Management, Almaty, Kazakhstan;
2 Research institute of cardiology and internal diseases, Almaty, Kazakhstan.
1 Арингазина А.М., Есимов Н.Б., Измаилова Н.Т. Программа управления заболеваниями в Республике Казахстан. Medicina (Almaty). 2019. №1(199). С. 43-46
2 Джумагазиева О.Д., Құмар А.Б., Мартыкенова Д.С., Изекенова А.К. Ауруларды басқару бағдарламасындағы бағалау индикаторлары. Вестник КазНМУ, №4 2019. С. 520-523.
3 Жорабек С.Б., Құмар А.Б., Кошербаева Л.К., Джумагазиева О.Ж. Созылмалы аурулар кезіндегі науқастардың өзін-өзі басқаруы. Вестник КазНМУ, 2019. №4. С.466-470.
4 Кумар А.Б., Кошербаева Л.К. Программа управления заболеваниями: монография. - Алматы: КазНМУ, 2019. – 227с.
5 Кумар А.Б., Кошербаева Л.К., Абикулова А.К., Джумагазиева О.Ж., Изекенова А.К., Жорабек С.Б. Нужды и потребности в самообслуживании у пациентов с хроническими заболеваниями. Вестник КазНМУ, 2019. №4. С. 474-478.
6 Кошербаева Л.К., Есназарова Г.С., Абикулова А.К., Кумар А.Б., Толганбаева К.А., Изекенова А.К. Оценка влияния школы здоровья на модифицируемые факторы риска артериальной гипертонии у пациентов, участвующих в программе управления заболеванием. Вестник КазНМУ, 2019. №4. С.470-474.
7 Тлемисова В.Б., Жумагулов Т.Т., Калманбаева К.Ж. Программа управления заболеваниями по трем нозологиям (артериальная гипертензия, сахарный диабет, хроническая сердечная недостаточность). Journal of Health Development. 2016. №3-4. С.20-21.
8 2013 жылда Қазақстан Республикасы халқының денсаулығы және денсаулық Е 40 сақтау ұйымдарының қызметі=Здоровье населения Республики Казахстан и деятельность организаций здравоохранения в 2013 году: Стат. жинақ.-Астана, 2014.-356 б.-қазақша, орысша.
9 2022 жылда Қазақстан Республикасы халқының денсаулығы және денсаулық сақтау ұйымдарының қызметі=Здоровье населения Республики Казахстан и деятельность организаций здравоохранения в 2022 году: Стат. жинақ. - Астана. 2023. -3 40б. - қазақша. Орысша
10 Al Habeeb W. Heart failure disease management program: A review. Medicine (Baltimore). 2022 Aug 5. 101(31):e29805. doi: 10.1097/MD.0000000000029805. PMID: 35945723. PMCID: PMC9351896.
11 Audi G., Korologou A., Koutelekos I., et al. Factors affecting health related quality of life in hospitalized patients with heart failure. Cardiol Res Pract. 2017. 2017:1–12
12 Boyde M., Peters R., New N., Hwang R., Ha T., Korczyk D. Self-care educational intervention to reduce hospitalisations in heart failure: A randomised controlled trial. Eur. J. Cardiovasc. Nurs. 2018. 17:178–185. doi:10.1177/1474515117727740.
13 Charais C., Bowers M., Do O.O., Smallheer B. Implementation of a Disease Management Program in Adult Patients With Heart Failure. Prof Case Manag. 2020 Nov/Dec. 25(6):312-323. doi: 10.1097/NCM.0000000000000413. PMID: 33017366.
14 Charchar F.J., Prestes P.R., Mills C., et al. Lifestyle management of hypertension: International Society of Hypertension position paper endorsed by the World Hypertension League and European Society of Hypertension. J Hypertens. 2024. 42(1):23-49. doi:10.1097/HJH.0000000000003563
15 Cho J.Y., Cho D.H., Youn J.C., et al. Korean Society of Heart Failure Guidelines for the Management of Heart Failure: Definition and Diagnosis. Korean Circ J. 2023. 53(4):195-216. doi:10.4070/kcj.2023.0046
16 Duan Y., Li Z., Zhong Q., Rao C., Hua Y., Wu R., Dong J., Li D., Wang W., He K. Efficacy of disease management program used among patients with chronic heart failure: protocol for a systematic review and network meta-analysis. Syst Rev. 2023 Feb 28. 12(1):27. doi: 10.1186/s13643-023-02183-8. PMID: 36855208. PMCID: PMC9972626.
17 Healy L., Ledwidge M., Gallagher .J, Watson C., McDonald K. Developing a disease management program for the improvement of heart failure outcomes: the do's and the don'ts. Expert Rev Cardiovasc Ther. 2019 Apr. 17(4):267-273. doi: 10.1080/14779072.2019.1596798. Epub 2019 Apr 8. PMID: 30916595.
18 Informed Health. What Are Disease Management Programs (DMPs)? Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2016. Available at https://www.ncbi.nlm.nih.gov/books/NBK279412/.
19 Kim N. An introduction to chronic disease management programs to strengthen community centered primary care and future plans for improvement (in Korean). Health Insur Rev Assess Serv Policy Trends 2018.12:18–27.
20 Linden A., Adams J.L., Roberts N. An assessment of the total population approach for evaluating disease management program effectiveness. Dis Manag. 2003 Summer. 6(2):93-102. doi: 10.1089/109350703321908478. PMID: 14577903.
21 Nolte E., Knai C., Saltman R. Assessing Chronic Disease Management in European Health Systems: Concepts and Approaches. Copenhagen, Denmark: European Observatory on Health Systems and Policies. 2014.
22 Rice H., Say R., Betihavas V. The effect of nurse-led education on hospitalisation, readmission, quality of life and cost in adults with heart failure. A systematic review. Patient Educ. Couns. 2018. 101:363–374. doi:10.1016/j.pec.2017.10.002.
23 Takeda A., Martin N., Taylor R.S., Taylor S.J.C. Disease management interventions for heart failure. Cochrane Database of Systematic Reviews 2019, Issue 1. Art. No.: CD002752. DOI: 10.1002/14651858.CD002752.pub4.
Number of Views: 39
Category of articles:
Original article
Bibliography link
Konysbekova A., Pashimov M., Abikulova A., Seiduanova L., Jumagaziyeva O., Qumar A. Results of the implementation of the disease management program on chronic heart failure in the Republic of Kazakhstan // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (6), pp. 56-63. doi 10.34689/SH.2024.26.6.007Related publications:
THE RELATIONSHIP BETWEEN BODY MASS INDEX AND BONE MINERAL DENSITY IN THE MIDDLE-AGED AND ELDERLY POPULATION
CLINICAL, MORPHOLOGICAL AND MORPHOMETRIC ASSESSMENT OF GRANULOMATOUS INFLAMMATION IN SARCOIDOSIS AND PULMONARY TUBERCULOSIS
DRUG-INDUCED LIVER INJURY IN HIV-INFECTED PATIENTS WITH ACTIVE TUBERCULOSIS: COMPARATIVE LABORATORY CHARACTERIZATION
RESULTS OF THE IMPLEMENTATION OF THE DISEASE MANAGEMENT PROGRAM ON CHRONIC HEART FAILURE IN THE REPUBLIC OF KAZAKHSTAN
COMORBIDITY IN OSTEOARTHRITIS